首页> 外国专利> AUTOLOGOUS TUMOR ORGANOID AND IMMUNE CELL CO-CULTURES AND METHODS OF USE AS PREDICTIVE MODELS FOR PANCREATIC CANCER TREATMENT

AUTOLOGOUS TUMOR ORGANOID AND IMMUNE CELL CO-CULTURES AND METHODS OF USE AS PREDICTIVE MODELS FOR PANCREATIC CANCER TREATMENT

机译:自体肿瘤有机体和免疫细胞共培养和用途作为胰腺癌治疗的预测模型

摘要

A method for preparing an autologous pancreatic tumor organoid and immune cell co-culture is provided, including: culturing pancreatic tumor cells obtained from a patient in a culture medium to provide a pancreatic tumor organoid and an organoid-conditioned medium; pulsing dendritic cells derived from the patient with a portion of the organoid-conditioned medium; contacting the pulsed dendritic cells with cytotoxic T lymphocytes (CTLs) obtained from the patient in the organoid-conditioned medium to activate the CTLs; isolating the activated CTLs; and co-culturing the pancreatic tumor organoid with the activated CTLs and myeloid derived suppressor cells (MDSCs) derived from the patient, to obtain an autologous pancreatic tumor organoid and immune cell co-culture that mimics the patient's pancreatic tumor microenvironment. Also provided are co-cultures obtained by the disclosed methods and methods of screening and determining whether a patient is likely to benefit from a candidate therapy.
机译:提供了一种制备自体胰腺肿瘤有机体和免疫细胞共培养的方法,包括:培养从培养基中的患者获得的胰腺肿瘤细胞,以提供胰腺肿瘤有机体和有机状条件培养基;脉冲树枝状细胞衍生自患者的有机体调节培养基的一部分;将脉冲树突状细胞与从患者中的细胞毒性T淋巴细胞(CTL)接触在有机体调节培养基中以激活CTL;隔离激活的CTL;并与衍生自患者的活化的CTL和髓样衍生抑制细胞(MDSC)共同培养胰腺肿瘤有机体,以获得自体胰腺肿瘤有机体和免疫细胞共培养,以模仿患者的胰腺肿瘤微环境。还提供了通过所公开的方法和方法获得的共培养物和筛选和确定患者是否可能受益于候选疗法的方法。

著录项

  • 公开/公告号EP3914266A1

    专利类型

  • 公开/公告日2021-12-01

    原文格式PDF

  • 申请/专利权人 UNIVERSITY OF CINCINNATI;

    申请/专利号EP20200745876

  • 发明设计人 ZAVROS YANA;HOLOKAI LORYN;

    申请日2020-01-24

  • 分类号A61K35/13;A61P35;C12N5/071;C12N5/09;G01N33/50;

  • 国家 EP

  • 入库时间 2022-08-24 22:14:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号